Skip to main content
Market intelligence
AXSMHealthcare

Axsome Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 3, 2026Mark L. JacobsonChief Operating OfficerSale10,000$208.65$2,086,500
Aug 6, 2026Herriot TabuteauChief Executive OfficerSale49,664$212.19$10,538,303
Jul 1, 2026Herriot TabuteauChief Executive OfficerSale49,666$240.25$11,932,257